InspireMD Inc.

NSPR | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.78

+$0.03 (+4.00%)

Sep 22, 2026, 11:50 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+4.00%

(1D)

Rating

Updated: Aug 10, 2026

36.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $36.53M

1D Range

0.75 0.79

52W Range

0.63 2.57

Valuation (TTM)

PE -1.50

PB 1.11

EV/EBITDA -0.17

Valuation (NTM)

Forward PE N/A

Forward PEG 0.07

Price Target $3.50

Cash Flow

FCF Yield -120.9%

SBC Adj. FCF Yield -151.4%

SBC Impact -25.2%

Margins

Gross Margin 18.1%

Operating Margin -494.0%

FCF Margin -391.7%

Growth (CAGR)

Revenue 3Y | 5Y 26.6% | 27.8%

Dil EPS 3Y | 5Y 22.9% | 36.0%

FCF 3Y | 5Y -38.7% | -28.2%

Returns

ROA -86.3%

ROE -79.2%

ROIC -153.0%

Financial Health

Net Cash

$28.45M

Current Ratio 3.80

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

InspireMD, Inc., an Israel-based medical technology company established in 2005, specializes in creating and commercializing advanced medical devices. Its core expertise lies in the proprietary MicroN...

Sector Healthcare

Industry Medical - Devices

Employees 127

IPO Date Apr 11, 2011

Website www.inspiremd.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 10, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$3.50

Upside

+348.72%

Buy (1)

Hold (0)

Sell (0)

Analyst Details ➞